NCT06130722
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06130722
Title First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Suzhou Forlong Biotechnology Co.,Ltd,
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
HOAG Memorial Hospital Presbyterian Newport Beach California 92663 United States Details
Moores Cancer Center at UCSD Health San Diego California 92037 United States Details
Gabriel Cancer Center Canton Ohio 44718 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field